279 related articles for article (PubMed ID: 12829822)
21. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
22. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
Burrel S; Deback C; Agut H; Boutolleau D
Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
[TBL] [Abstract][Full Text] [Related]
23. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus resistance to antiviral drugs.
Morfin F; Thouvenot D
J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
[TBL] [Abstract][Full Text] [Related]
25. Exonuclease-deficient polymerase mutant of herpes simplex virus type 1 induces altered spectra of mutations.
Hwang YT; Hwang CB
J Virol; 2003 Mar; 77(5):2946-55. PubMed ID: 12584319
[TBL] [Abstract][Full Text] [Related]
26. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
28. Testing of herpes simplex virus for resistance to antiviral drugs.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Virulence; 2010; 1(6):555-7. PubMed ID: 21178503
[TBL] [Abstract][Full Text] [Related]
29. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
[TBL] [Abstract][Full Text] [Related]
30. Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
Schalkwijk HH; Shewakramani NR; Das K; Andrei G; Snoeck R
Antimicrob Agents Chemother; 2024 May; 68(5):e0011024. PubMed ID: 38619252
[TBL] [Abstract][Full Text] [Related]
31. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
[TBL] [Abstract][Full Text] [Related]
32. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
Bohn K; Zell R; Schacke M; Wutzler P; Sauerbrei A
Antivir Ther; 2011; 16(7):989-97. PubMed ID: 22024514
[TBL] [Abstract][Full Text] [Related]
33. A mutation in the DNA polymerase accessory factor of herpes simplex virus 1 restores viral DNA replication in the presence of raltegravir.
Zhou B; Yang K; Wills E; Tang L; Baines JD
J Virol; 2014 Oct; 88(19):11121-9. PubMed ID: 25008933
[TBL] [Abstract][Full Text] [Related]
34. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
[TBL] [Abstract][Full Text] [Related]
35. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene.
Andrei G; Snoeck R; De Clercq E; Esnouf R; Fiten P; Opdenakker G
J Gen Virol; 2000 Mar; 81(Pt 3):639-48. PubMed ID: 10675401
[TBL] [Abstract][Full Text] [Related]
36. Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.
Tian W; Hwang YT; Lu Q; Hwang CB
J Virol; 2009 Jul; 83(14):7194-201. PubMed ID: 19420083
[TBL] [Abstract][Full Text] [Related]
37. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir.
Kamiyama T; Kurokawa M; Shiraki K
J Gen Virol; 2001 Nov; 82(Pt 11):2761-2765. PubMed ID: 11602787
[TBL] [Abstract][Full Text] [Related]
39. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
